E47 modulates hepatic glucocorticoid action
Glucocorticoids (GCs) are widely used anti-inflammatory drugs; however, long-term treatment causes metabolic side effects. Here, the authors show that E47 is a modulator of glucocorticoid receptor activity for a subset of target genes in mouse liver, and that loss of E47 protects mice from hyperglyc...
Guardado en:
Autores principales: | M. Charlotte Hemmer, Michael Wierer, Kristina Schachtrup, Michael Downes, Norbert Hübner, Ronald M. Evans, N. Henriette Uhlenhaut |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c66a0d65c60642e39dc4efc1ae62484e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
por: Erika Harno, et al.
Publicado: (2021) -
Modulation by Ozone of Glucocorticoid-Regulating Factors in the Lungs in Relation to Stress Axis Reactivity
por: Jith Thomas, et al.
Publicado: (2021) -
Impact of cadmium exposure during pregnancy on hepatic glucocorticoid receptor methylation and expression in rat fetus.
por: Paula Castillo, et al.
Publicado: (2012) -
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states
por: Simiao Xu, et al.
Publicado: (2021) -
Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α
por: Sara Della Torre, et al.
Publicado: (2021)